Clinical trial Recruiting at 1 site Observational Ages 40 to 75

Predicting recurrence of high-risk colorectal polyps using microbiota and metabolites

Official title: Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy

Run by Peking Union Medical College Hospital · NCT06957626 · Data updated 2026-11-12

This study is trying to see if the bacteria and substances in the gut can help predict if high-risk colorectal polyps will come back after they've been removed.

Quick facts

Study typeObservational
Ages40 Years to 75 Years
SexAll
Enrollment150 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedApril 25, 2023
Main results expectedApril 30, 2026
Study endsApril 30, 2026
Registry record updatedJuly 1, 2025
Trial IDNCT06957626 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 40-75 years who have at least one high-risk colorectal polyp and are undergoing colonoscopy.

Probably not a fit

Patients with severe physical diseases, previous gastrointestinal surgeries, or existing colorectal cancer will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study analyzes the characteristics of intestinal microbiota in patients who have undergone polypectomy for high-risk colorectal polyps. It aims to understand the relationship between microbial communities and the recurrence of these polyps, which could provide insights into the etiology of adenoma recurrence. By developing a prediction model based on microbiota and metabolites, the research seeks to enhance patient management and outcomes following polypectomy.

Why it matters

Potential benefit: If successful, this study could lead to a predictive tool that helps identify patients at higher risk for polyp recurrence, allowing for more tailored surveillance and intervention strategies.

How similar studies have gone: While the specific approach of using microbiota and metabolites for prediction is novel, similar studies have shown promise in understanding the role of microbiota in colorectal health.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients aged 40-75 years who undergo the colonoscopy with at least 1 advanced premalignant polyps or ≥ 3 adenoma

Exclusion Criteria:

* patient with severe physical diseases that prevented them from adhering to the examination requirements,
* patient with coagulopathy or other contraindications for biopsy or polypectomy,
* patient with previous surgical procedures on the gastrointestinal tract,
* presence of colorectal cancer or other malignant tumor at baseline
* presence of inflammatory bowel disease or hereditary polyposis syndromes (such as family adenomatous polyposis or Lynch syndrome)
* within 1 month before enrollment, oral antibiotics and probiotics were taken;
* inability to provide informed consent or refusal to participate in the study.

Where it's running

  • Peking Union Medical College Hospital, 1 Shuaifuyuan, Dongcheng District, Beijing, China
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.